Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Director departure
CC transcript

ALBANY MOLECULAR RESEARCH INC (AMRI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/31/2017 8-K Quarterly results
08/18/2017 8-K Quarterly results
07/10/2017 8-K Form 8-K - Current report:
06/29/2017 8-K Form 8-K - Current report
06/06/2017 8-K Form 8-K - Current report
06/01/2017 8-K Form 8-K - Current report
05/09/2017 8-K Form 8-K - Current report
02/21/2017 8-K Form 8-K - Current report
12/22/2016 8-K Form 8-K - Current report
11/08/2016 8-K Quarterly results
Docs: "AMRI Announces Third Quarter 2016 Results"
09/23/2016 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of EY S.p.A",
"Consent of EY S.p.A",
"Audited consolidated financial statements of Euticals as of December 31, 2015 and 2014 and for the three years ended December 31, 2015, 2014 and 2013",
"Audited consolidated financial statements of Euticals as of December 31, 2015 and 2014 and for the three years ended December 31, 2015, 2014 and 2013",
"Unaudited pro forma condensed combined financial statements and related notes thereto of Albany Molecular Research, Inc. at June 30, 2016 and for the six months ended June 30, 2016 and the year ended December 31, 2015",
"Unaudited pro forma condensed combined financial statements and related notes thereto of Albany Molecular Research, Inc. at June 30, 2016 and for the six months ended June 30, 2016 and the year ended December 31, 2015"
08/29/2016 8-K Cost Associated with Exit or Disposal Activities, Material Impairments
08/04/2016 8-K Quarterly results
Docs: "AMRI Announces Second Quarter 2016 Results"
04/12/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/04/2013 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Amendment to Call Option Transaction Confirmation, between Albany Molecular Research, Inc. and JPMorgan Chase Bank, National Association, London Branch",
"Amendment to Call Option Transaction Confirmation, between Albany Molecular Research, Inc. and Morgan Stanley & Co. International plc",
"Additional Warrants Confirmation, between Albany Molecular Research, Inc. and JPMorgan Chase Bank, National Association, London Branch",
"Additional Warrants Confirmation, between Albany Molecular Research, Inc. and Morgan Stanley & Co. International plc"
11/06/2013 8-K Quarterly results
Docs: "AMRI Announces Third Quarter 2013 Results and Raises Full Year EPS Guidance"
10/17/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMRI Announces Senior Level Leadership Appointment for Discovery Services"
09/10/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMRI Announces Executive Leadership Changes"
08/12/2013 8-K Other Events
08/07/2013 8-K Quarterly results
Docs: "AMRI Announces Second Quarter 2013 Results"
06/06/2013 8-K Submission of Matters to a Vote of Security Holders
05/08/2013 8-K Quarterly results
Docs: "Total First Quarter Revenue up 11% at $59.4 Million and Adjusted EPS increased to $0.23"
02/12/2013 8-K Quarterly results
Docs: "AMRI Announces Fourth Quarter 2012 Adjusted EPS of $0.17"
12/14/2012 8-K Regulation FD Disclosure
12/06/2012 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "AMRI Extends Long Term Supply Relationship with GE Healthcare"
11/30/2012 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "AMRI Realigns Discovery Services to Support Customer Demand"
11/06/2012 8-K Quarterly results
Docs: "AMRI Announces Third Quarter 2012 Results"
10/24/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/13/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer"
07/31/2012 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modifications to Rights ...
Docs: "AMRI Renews Shareholder Rights Plan"
06/07/2012 8-K Form 8-K - Current report
05/08/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "William S. Marth Appointed to AMRI’ s Board of Directors"
04/12/2012 8-K Form 8-K - Current report
04/05/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Employment Agreement, by and between the Company and Thomas E. D’ Ambra, Ph.D",
"Amended and Restated Employment Agreement, by and between the Company and Mark T. Frost",
"Amended and Restated Employment Agreement, by and between the Company and Steven R. Hagen, Ph.D",
"Amended and Restated Employment Agreement, by and between the Company and Bruce J. Sargent, Ph.D",
"Amended and Restated Employment Agreement, by and between the Company and Lori M. Henderson"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy